Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × etoposide phosphate × 90 days × Clear all

Sponsor

Conditions

Neuroblastoma 5 Rhabdoid Tumor 3 Medulloblastoma 3 Sarcoma, Ewing 2 Pinealoma 2 Lymphoma, B-Cell 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Ganglioneuroblastoma 2 Ependymoma 2 Brain Neoplasms 2 Solid Tumor 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive 1 Nervous System Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Histiocytosis, Langerhans-Cell 1

Interventions

pegaspargase 4 tislelizumab 1 sugemalimab 1 relatlimab 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Vorinostat 1 Valganciclovir 1 Transplantation 1 Therapeutics 1 Tacrolimus 1 Radiotherapy 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Oxaliplatin 1 Nivolumab 1 Mycophenolic Acid 1 Methylprednisolone 1 Immune Checkpoint Inhibitors 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Cyclophosphamide 1 Busulfan 1 Azacitidine 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡